Wexford Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,089
| Closed | -$120K | – | 294 |
|
|
2025
Q1 | $120K | Buy |
+1,089
| New | +$120K | 0.03% | 195 |
|
|
2017
Q3 | – | Sell |
-7,800
| Closed | -$359K | – | 178 |
|
|
2017
Q2 | $359K | Buy |
+7,800
| New | +$359K | 0.03% | 131 |
|
|
2016
Q3 | – | Sell |
-27,020
| Closed | -$1.23M | – | 179 |
|
|
2016
Q2 | $1.23M | Hold |
27,020
| – | – | 0.21% | 67 |
|
|
2016
Q1 | $1.07M | Buy |
+27,020
| New | +$1.07M | 0.21% | 72 |
|